• AIM: To perform a Meta-analysis to explore the correlation between metabolic syndrome and intraocular pressure (IOP).
INTRODUCTION
I ntraocular pressure (IOP), pressure within the eye, is exerted on the eye wall to prevent the collapse of the eyeball, higher than atmospheric pressure [1] . Elevated IOP has been certified to be associated with glaucoma [2] , which is characterized by a disorder of blood supply and optic disc cupping [3] . IOP is the only modifiable risk factor for glaucoma, and lowering IOP prevents the development and progression of the disease [4] . A large number of studies have shown the relationship between the IOP and several health problems, such as age, abdominal obesity, high blood pressure, diabetes and hyperglycemia, most of them share a single common mechanism that contributes to metabolic syndrome (MetS) [5] [6] [7] . MetS is a complex disorder defined by a cluster of interconnected risk factors, including abdominal obesity, raised blood pressure, hypertriglyceridemia, hyperglycemia, and low highdensity lipoprotein (HDL) cholesterol level [8] . The combination of these factors is often attributed to Gerald Reaven, who popularized the term "Syndrome X" in 1988 [9] . MetS is an important health problem worldwide which is associated with cardiovascular disease, type 2 diabetes mellitus, cancer, as well as ophthalmic disease [10] [11] [12] . Approximately 22.9% of the adults met the criteria for MetS from 2000 to 2010 in the United States [13] . Two of numerous and similar definitions for MetS are applied frequently, the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) [14] and the International Diabetes Federation (IDF) [15] . Several studies have suggested an epidemiological link between IOP and MetS [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , however, there is no synthesis of observational data that explores the relationship between them. Therefore, we conducted a Meta-analysis to certify the association between the MetS components and IOP.
MATERIALS AND METHODS Search Strategy
The present Meta-analysis was reported on the basis of the proposed MOOSE (Meta-Analysis of Observational Studies in Epidemiology) guidelines [26] and the Preferred Reporting Items for Systematic Reviews and Metaanalyses (PRISMA) [27] . Two independent observers (Wang YX and Tao JX) searched the following databases till November 30 th , 2017: PubMed and Embase. The databases were searched by using the keywords "intraocular pressure OR IOP OR glaucoma," AND "metabolic syndrome". In order to search all potential studies, we didn't restrict the starting year at initial retrieval. The reference lists of all retrieved articles were cross checked manually.
Inclusion and Exclusion Criteria
The inclusion criteria in this Meta-analysis were as follows: 1) studies reporting the correlation between MetS and IOP; 2) studies describing the diagnostic criteria of MetS; 3) studies describing the range of the normal IOP; 4) studies where Pearson's correlation coefficients or standardized betas or odds ratios (ORs) were reported; 5) studies depending on human-beings; 7) studies published as full-text articles in English. If the studies met the following selection criteria, they would be excluded: 1) meeting abstracts, case reports, reviews, Meta-analyses, comments and animal studies; 2) studies lacking necessary data for calculation, such as the Pearson's correlation coefficients or standardized betas or ORs of the IOP and MetS, and the number of the patients included in the studies; 3) studies undertaken on patients with other disorders; 4) studies published in the language different from English. Study Selection and Data Extraction All publications were categorized using Endnote X8 for Mac. Two reviewers (Wang YX, and Tao JX) screened all pertinent titles and abstracts for studies and then basing on full-text review was second performed. Articles were selected from included studies depending on first author, study design, study date, country of origin, sample size, participant age, gender, outcome ascertainment and diagnostic criteria of MetS. If a study did not clearly mention any above key points, we considered that it had been not performed. Measurement of Intraocular Pressure IOP was measured by non-contact tonometry in all the included studies except 3 studies, 2 [19] [20] of which used Goldmann applanation tonometer and 1 [22] of which used Kowa KT-800 tonometer for measurement. Moreover, all the measurements were conducted in the morning to minimize the effect of diurnal variation except 1 [22] study conducted in the afternoon. All the above ophthalmological measurements were performed by trained and experienced ophthalmologists or nurses.
Definition of Metabolic Syndrome Definition of MetS in this study was based on the National Cholesterol Education
Program Adult Treatment Panel III (NCEP ATP III) [14] or the International Diabetes Federation (IDF) criteria [15] .
NCEP ATP III criteria (the presence of any three or more of the following five syndromes): 1) abdominal obesity: waist circumference >102 cm (men) and >88 cm (women); 2) hypertriglyceridemia: serum triglyceride (TG) level ≥150 mg/dL or drug treatment for elevated TG; 3) low HDL-cholesterol: <40 mg/dL in men and <50mg/dL in women or drug treatment for low HDL-cholesterol; 4) high blood pressure: systolic blood pressure (SBP) ≥130 mm Hg and/or diastolic blood pressure (DBP) ≥85 mm Hg or drug treatment for elevated blood pressure (high blood pressure); 5) high fasting glucose (FBS): serum glucose level ≥100 mg/dL or on treatment for diabetes. IDF criteria (the presence of any two or more of the following five syndromes): 1) abdominal obesity: waist circumference >94 cm (men) and >80 cm (women); 2) hypertriglyceridemia: serum TG level ≥150 mg/dL or drug treatment for elevated TG; 3) low HDL-cholesterol: <40 mg/dL in men and <50 mg/dL in women or drug treatment for low HDL-cholesterol; 4) high blood pressure: SBP≥130 mm Hg and/or DBP≥85 mm Hg or drug treatment for elevated blood pressure (high blood pressure); 5) high FBS: serum glucose level ≥100 mg/dL or on treatment for diabetes. Statistical Analysis Statistical data (ORs, standardized betas) on the relation of IOP and MetS were extracted from each article and converted to Pearson correlation coefficients (r) [28] [29] . After unifying units into Pearson [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] fulfilled our inclusion and exclusion criteria, consisting of 4 studies [17] [18] [19] 24] about Pearson correlation coefficients, 5 studies [16, [20] [21] [22] 25] about standardized betas and 1 study [23] about OR.
All of the studies included in this Meta-analysis reported the relationship between MetS components and IOP (Table 1) . The extracted data from these individual studies were summarized which included 57 321 participants.
Metabolic Syndrome and Intraocular Pressure
The relationship between MetS and IOP were reported in 3 studies [16, [23] [24] Figure 2B ) that meant no statistical significance. Publication Bias Begg's test [30] and Egger's test [31] were used to evaluate the possible publication bias. For MetS and IOP, the P values for Begg's and Egger's test were 0.734 and 0.538 ( Figure 3F ). For MetS components and IOP, the P values of waist circumference, TG, SBP, DBP, and fasting glucose for Begg's test were 0.945, 0.300, 0.721, 0.283 and 1.000, respectively. The P values for Egger's test were 0.518, 0.211, 0.972, 0.125 and 0.844 (Figure 3) , respectively. All the data above showed no statistical significance, which meant no evidence of significant publication bias of this Metaanalysis. Our pooled Z of 0.47 indicated a higher prevalence of MetS in people with intraocular hypertension. In order to get to the bottom of the connection between them, we carried on the further study about MetS components and IOP. As it turned out, increased waist circumference, hypertriglyceridemia, high fasting glucose and high blood pressure were the parameters which drove the association between MetS and IOP. Many reports have indicated that, IOP increases in people with obesity whose waist circumference over 102 cm (men) and 88 cm (women) because of a decrease in the squeous humor outflow due to an increase in orbital fat and episcleral pressure [32] . Blood viscosity may increase along with the raise of red cell count, hemoglobin and hematocrit, and consequently increased outflow resistance of episcleral veins in the obese population [33] . Moreover, hypertriglyceridemia also caused an increase in episcleral pressure and a decrease in aqueous humor outflow owing to accumulation of orbital adipose tissue [34] [35] . Although the influence of systemic hypertension on glaucoma is complex, several mechanisms are suggested. The majority of studies considered that high blood pressure increased the pressure of ciliary artery in ocular, which increased the IOP because it induced more aqueous humor to be produced [36] .
While, some thought chronically elevated blood pressure may result in arteriosclerosis, changes in the size of the precapillary arterioles, and capillary dropout leading to increased resistance to blood flow and, thus, reduced perfusion [37] [38] . It has been reported that hyperglycemia may also be closely associated with IOP. However, the etiologic links between them remain unclear, several hypotheses have been advanced. One possible explanation was that elevated blood glucose resulted in the fluid shifts into the intraocular space from the osmotic gradient [39] . Hyperglycemia caused microvascular damage and may affect vascular autoregulation of the retain and optic nerve, which could reduce blood flow and impair oxygen diffusion [40] . On the other hand, neuronal and glial functions as well as metabolism in the retina may also be impaired which caused progressive retinal ganglion cell death and optic disk excavation followed by the IOP elevation [41] . Glaucoma is a multifactorial disease that the etiology is still not completely understood, but multiple previous studies had noted a strong relationship between IOP and glaucoma. IOP was the only known modifiable factor among age, genetic, family history or other ones and induce lesion by causing structural and functional damage [42] . The median follow-up study of six years confirmed the findings: the post-baseline progression factors included IOP, with every 1 mm Hg increase in IOP leading to a 12%-13% higher risk of progression [43] .
In a Meta-analysis of randomized clinical trials, treating high IOP was associated with a significant reduction in glaucoma development (0.56 hazards ratio) for patients at high-risk of converting to primary open-angle glaucoma. Patients in the treatment arm of these trials did not progress to glaucoma diagnoses in 63%-91% of the cases [44] . At the same time, in the wake of changing lifestyles among more and more people, the prevalence of the MetS increased dramatically in the few years. According to our Meta-analysis the epidemic of the MetS or even its components have a huge impact on the IOP, that is to say, there may be a relationship between MetS and glaucoma. Lifestyle intervention may play an important role in the treatment of glaucoma by regulating the lower IOP. Several limitations needed to be considered in our study. First, the majority of studies were from Asia, most of them were yellow race, selection bias was inevitable. Second, our findings were primarily based on results derived from cross-sectional analyses or observational studies, which may subject to unmeasured confounding and other potential biases. Third, significant heterogeneity was observed in the overall analysis. The heterogeneity could be explained by differences in populations, regions, gender, age, and confounding factors such as smoking of exposure ascertainment. Fourth, the absence of uniform diagnostic criteria of MetS may increase the incomparability among studies. In conclusions, our analysis indicated that MetS and its components besides HDL were associated with IOP. Moreover, the treatment of the MetS may have a potential role in preventing elevated IOP, which may have benefit in several eye diseases.
